Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis confirms positive benefit-risk profile of Gilenya following CHMP review
Novartis confirms positive benefit-risk profile of Gilenya following CHMP review
Novartis confirms positive benefit-risk profile of Gilenya following CHMP review
Submitted by
admin
on April 20, 2012 - 10:38am
Source:
The Fly on the Wall
News Tags:
CHMP
Novartis
MS
multiple sclerosis
Headline:
Novartis confirms positive benefit-risk profile of Gilenya following CHMP review
Do Not Allow Advertisers to Use My Personal information
